Orthocell Limited (OCC.AX)
AUD 1.25
(-0.4%)
AUD 1.25
(-0.4%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 22.08 Million AUD | -5.86% |
| 2023 | 23.45 Million AUD | -16.2% |
| 2022 | 27.99 Million AUD | 1039.68% |
| 2021 | 2.45 Million AUD | 8.34% |
| 2020 | 2.26 Million AUD | -21.1% |
| 2019 | 2.87 Million AUD | 0.54% |
| 2018 | 2.85 Million AUD | 16.81% |
| 2017 | 2.44 Million AUD | 9.77% |
| 2016 | 2.22 Million AUD | 3.54% |
| 2015 | 2.15 Million AUD | -57.48% |
| 2014 | 5.06 Million AUD | 636.52% |
| 2013 | 687.24 Thousand AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 FY | 22.08 Million AUD | -5.86% |
| 2024 Q2 | 22.73 Million AUD | 0.0% |
| 2024 Q4 | 22.08 Million AUD | 0.0% |
| 2023 FY | 23.45 Million AUD | -16.2% |
| 2023 Q4 | 23.45 Million AUD | 0.0% |
| 2023 Q2 | 24.4 Million AUD | 0.0% |
| 2022 Q2 | 2.45 Million AUD | 0.0% |
| 2022 FY | 27.99 Million AUD | 1039.68% |
| 2022 Q4 | 27.99 Million AUD | 0.0% |
| 2021 Q4 | 2.45 Million AUD | 0.0% |
| 2021 Q2 | 2.43 Million AUD | 0.0% |
| 2021 FY | 2.45 Million AUD | 8.34% |
| 2020 Q2 | 1.78 Million AUD | 0.0% |
| 2020 Q4 | 2.26 Million AUD | 0.0% |
| 2020 FY | 2.26 Million AUD | -21.1% |
| 2019 Q4 | 2.87 Million AUD | 0.0% |
| 2019 Q2 | 2.78 Million AUD | 0.0% |
| 2019 FY | 2.87 Million AUD | 0.54% |
| 2018 Q4 | 2.85 Million AUD | 0.0% |
| 2018 FY | 2.85 Million AUD | 16.81% |
| 2018 Q2 | 1.65 Million AUD | 0.0% |
| 2017 FY | 2.44 Million AUD | 9.77% |
| 2017 Q4 | 2.44 Million AUD | 0.0% |
| 2017 Q2 | 1.34 Million AUD | 0.0% |
| 2016 Q2 | 1.11 Million AUD | 0.0% |
| 2016 FY | 2.22 Million AUD | 3.54% |
| 2016 Q4 | 2.22 Million AUD | 0.0% |
| 2015 Q4 | 2.15 Million AUD | 0.0% |
| 2015 Q2 | 1 Million AUD | 0.0% |
| 2015 FY | 2.15 Million AUD | -57.48% |
| 2014 FY | 5.06 Million AUD | 636.52% |
| 2014 Q4 | 4.3 Million AUD | 0.0% |
| 2014 Q2 | 857.45 Thousand AUD | 0.0% |
| 2013 Q4 | 687.24 Thousand AUD | 0.0% |
| 2013 Q3 | 687.24 Thousand AUD | 0.0% |
| 2013 FY | 687.24 Thousand AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 4.22 Million AUD | -422.154% |
| Anatara Lifesciences Ltd | 306.84 Thousand AUD | -7096.581% |
| Zelira Therapeutics Limited | 9.35 Million AUD | -136.012% |
| Biome Australia Limited | 5.37 Million AUD | -310.973% |
| Patrys Limited | 691.36 Thousand AUD | -3094.063% |
| Imugene Limited | 33.14 Million AUD | 33.372% |
| Noxopharm Limited | 1.28 Million AUD | -1613.673% |
| PYC Therapeutics Limited | 10.18 Million AUD | -116.835% |
| Chimeric Therapeutics Limited | 12.8 Million AUD | -72.479% |
| Prescient Therapeutics Limited | 2.32 Million AUD | -849.561% |
| Proteomics International Laboratories Limited | 1.62 Million AUD | -1258.158% |
| Cynata Therapeutics Limited | 1.17 Million AUD | -1785.704% |
| CSL Limited | 27.88 Billion AUD | 99.921% |
| Arovella Therapeutics Limited | 2.05 Million AUD | -973.726% |
| Bio-Gene Technology Limited | 368.44 Thousand AUD | -5893.453% |
| Clinuvel Pharmaceuticals Limited | 28.11 Million AUD | 21.448% |
| Starpharma Holdings Limited | 8.69 Million AUD | -153.882% |
| Nanollose Limited | 465.64 Thousand AUD | -4642.396% |
| Memphasys Limited | 5.59 Million AUD | -294.869% |
| Invex Therapeutics Ltd | 431.63 Thousand AUD | -5016.103% |
| NeuroScientific Biopharmaceuticals Limited | 85.68 Thousand AUD | -25672.482% |
| Amplia Therapeutics Limited | 3.42 Million AUD | -544.41% |
| Botanix Pharmaceuticals Limited | 3.73 Million AUD | -491.698% |
| Island Pharmaceuticals Limited | 1.04 Million AUD | -2011.91% |
| Race Oncology Limited | 1.91 Million AUD | -1052.283% |
| Nyrada Inc. | 855.63 Thousand AUD | -2480.854% |
| Telix Pharmaceuticals Limited | 249.39 Million AUD | 91.145% |
| Dimerix Limited | 13.89 Million AUD | -58.947% |
| PharmAust Limited | 896.6 Thousand AUD | -2362.911% |
| Immutep Limited | 10.97 Million AUD | -101.124% |
| Clarity Pharmaceuticals Ltd | 8.33 Million AUD | -165.042% |
| Alterity Therapeutics Limited | 5.42 Million AUD | -307.002% |
| BTC Health Limited | 203.94 Thousand AUD | -10727.582% |
| Acrux Limited | 5.68 Million AUD | -288.3% |
| Neuren Pharmaceuticals Limited | 42.76 Million AUD | 48.36% |
| Biotron Limited | 737.5 Thousand AUD | -2894.223% |
| Tissue Repair Ltd | 1.35 Million AUD | -1534.656% |
| AdAlta Limited | 3.54 Million AUD | -523.353% |
| Radiopharm Theranostics Limited | 44.68 Million AUD | 50.579% |
| Hexima Limited | 248.67 Thousand AUD | -8780.298% |
| AnteoTech Limited | 4.07 Million AUD | -441.871% |
| Paradigm Biopharmaceuticals Limited | 3.58 Million AUD | -516.086% |
| Recce Pharmaceuticals Ltd | 15.89 Million AUD | -38.942% |
| Avecho Biotechnology Limited | 941.54 Thousand AUD | -2245.374% |
| Actinogen Medical Limited | 1.61 Million AUD | -1267.034% |
| Immuron Limited | 2.84 Million AUD | -677.414% |
| Argenica Therapeutics Limited | 2.42 Million AUD | -809.979% |